C

Cresilon

Plant-based hemostatic gel for bleeding control

Quality Assurance Technician

Inspection & Test +1Confirmed live in the last 24 hours
Full-timeBrooklyn, NY, USA$25 /hr

About the Job

Requirements

  • A high school diploma or equivalent is required.
  • Experience in GMP and FDA-regulated environments is required.
  • Ability to obtain gowning qualification under Cresilon's standard operating procedure.
  • Ability to lift, walk, stand, reach, pull, and push.

Responsibilities

  • Sample and visually inspect final products and raw materials, and perform other testing under the direction of the QA Operations Manager.
  • Perform line-clearance activities and in-process inspections.
  • Monitor routine manufacturing operations for compliance with applicable procedures.
  • Transfer materials between facilities.
  • Operate testing equipment, including force testers, torque testers, and balances.
  • Report deviations in products, components, raw materials, and equipment according to applicable procedures.
  • Perform document-control activities, including printing logbooks and batch records.
  • Transcribe data into digital systems to track quality metrics.
  • Review batch records and support routine batch disposition.

Desired Qualifications

  • A two- or four-year degree in Engineering, Science, or Technology/Biotechnology is preferred.
  • Experience with ISO 13485:2016 is preferred.
  • One year of experience in a regulated industry is highly desirable.

About the Company

Cresilon

Plant-based hemostatic gel for bleeding control

Cresilon makes medical devices that stop bleeding with a plant-based adhesive gel. Its main product, VETIGEL, is a fast-acting gel designed to control bleeding in veterinary patients, and Cresilon serves human trauma and surgical markets as well. The gel is applied to a wound and works to seal and promote clotting within seconds without needing manual pressure. Cresilon differentiates itself by offering a gel-based hemostat and by being among the first to target veterinary applications with a rapid, easy-to-use solution, along with direct sales and partnerships (for example, the VerticalVet Preferred Partnership) to reach clinics and hospitals. The company’s goal is to broaden the gel technology’s uses to improve wound care and save lives across veterinary, human trauma, and surgical settings.

Company size
51-200
Company stage
Early VC
Total funding
$116.5M
Headquarters
New York City, New York
Founded
2010

Recently Posted Jobs

Explore more opportunities at Cresilon

See more jobs